Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Ekso Bionics Holdings Inc’s stock clocked out at $3.57, up 13.33% from its previous closing price of $3.15. In other words, the price has increased by $13.33 from its previous closing price. On the day, 0.53 million shares were traded. EKSO stock price reached its highest trading level at $3.79 during the session, while it also had its lowest trading level at $3.08.
Ratios:
To gain a deeper understanding of EKSO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.77 and its Current Ratio is at 2.35. In the meantime, Its Debt-to-Equity ratio is 0.44 whereas as Long-Term Debt/Eq ratio is at 0.31.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EKSO now has a Market Capitalization of 8449012 and an Enterprise Value of 4475230. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.49 while its Price-to-Book (P/B) ratio in mrq is 0.53. Its current Enterprise Value per Revenue stands at 0.255 whereas that against EBITDA is -0.504.
Stock Price History:
The Beta on a monthly basis for EKSO is 0.85, which has changed by -0.77440757 over the last 52 weeks, in comparison to a change of 0.12463009 over the same period for the S&P500. Over the past 52 weeks, EKSO has reached a high of $22.95, while it has fallen to a 52-week low of $2.73. The 50-Day Moving Average of the stock is -31.25%, while the 200-Day Moving Average is calculated to be -62.20%.
Shares Statistics:
It appears that EKSO traded 210.17K shares on average per day over the past three months and 458180 shares per day over the past ten days. A total of 2.40M shares are outstanding, with a floating share count of 2.11M. Insiders hold about 12.09% of the company’s shares, while institutions hold 10.64% stake in the company. Shares short for EKSO as of 1749772800 were 27543 with a Short Ratio of 0.13, compared to 1747267200 on 13561. Therefore, it implies a Short% of Shares Outstanding of 27543 and a Short% of Float of 1.1900000000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
In the current quarter, 2 analysts expect revenue to total $4.31M. It ranges from a high estimate of $4.62M to a low estimate of $4M. As of the current estimate, Ekso Bionics Holdings Inc’s year-ago sales were $4.95MFor the next quarter, 2 analysts are estimating revenue of $4.15M. There is a high estimate of $4.29M for the next quarter, whereas the lowest estimate is $4M.
A total of 2 analysts have provided revenue estimates for EKSO’s current fiscal year. The highest revenue estimate was $18.22M, while the lowest revenue estimate was $17M, resulting in an average revenue estimate of $17.61M. In the same quarter a year ago, actual revenue was $17.93MBased on 2 analysts’ estimates, the company’s revenue will be $25.06M in the next fiscal year. The high estimate is $26.9M and the low estimate is $23.21M.
